Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 3/20 | 0.55 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 2/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
| ▸ | CD38 | P28907 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4153724 | 0.90 | MAP4K4 (0.49) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4155753 | 0.88 | S1PR1 (0.46) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4143243 | 0.88 | FYN (0.57) | VNN1RPS6KB1CLK1FYNPARP1 | |
| SCHEMBL4156327 | 0.86 | CLK1 (0.50) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4190030 | 0.85 | FYN (0.60) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4143026 | 0.85 | MKNK1 (0.50) | VNN1RPS6KB1HDAC1CLK1FYN | |
| SCHEMBL4140370 | 0.85 | CLK1 (0.48) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4155055 | 0.84 | FYN (0.53) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4140030 | 0.84 | FYN (0.53) | VNN1RPS6KB1HDAC1HDAC6CLK1 | |
| SCHEMBL4191971 | 0.82 | HDAC1 (0.47) | HDAC1HDAC2CLK1FYNMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163515-A1 | Compounds Which Bind to the Active Site of Protein Kinase Enzymes | BIOFOCUS DISCOVERY LTD. | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163515-A1 | Compounds Which Bind to the Active Site of Protein Kinase Enzymes | ROCK1, ROCK2, CIT | VNN1 4724/4885RPS6KB1 736/4885AKT1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.